(Q36597453)

15 August 2017

title

Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma (English)

1 reference

15 August 2017

6

Robert J Motzer

1 reference

15 August 2017

Revathi Suppiah

1

1 reference

15 August 2017

Philip E Shaheen

2

1 reference

15 August 2017

Paul Elson

3

1 reference

15 August 2017

Seema A Misbah

4

1 reference

15 August 2017

Laura Wood

5

1 reference

15 August 2017

Slyvie Negrier

7

1 reference

15 August 2017

Steven W Andresen

8

1 reference

15 August 2017

Ronald M Bukowski

9

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 October 2006

1 reference

15 August 2017

number of pages

8

1 reference

inferred from page(s)

published in

Cancer

1 reference

15 August 2017

volume

107

1 reference

15 August 2017

issue

8

1 reference

15 August 2017

page(s)

1793-1800

1 reference

Role of platelets in tumor cell metastases

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22237

Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22237

21 January 2018

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22237

7 January 2021

Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22237

7 January 2021

Prognostic factors in renal cell and bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22237

7 January 2021

Prognostic factors in patients with renal cell carcinoma: retrospective analysis of 675 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22237

7 January 2021

Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22237

7 January 2021

Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22237

7 January 2021

THROMBOCYTOSIS ASSOCIATED WITH MALIGNANT DISEASE

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22237

7 January 2021

Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22237

7 January 2021

Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'Immunothérapie

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22237

7 January 2021

Prognostic significance of thrombocytosis in renal cell carcinoma patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22237

7 January 2021

Significance of thrombocytosis for determining prognosis in patients with localized renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22237

7 January 2021

Hemostatic function in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22237

7 January 2021

Abnormalities of blood coagulation tests in patients with cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22237

7 January 2021

Coagulation disorders in cancer.I. Clinical and laboratory studies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22237

7 January 2021

Elevated serum interleukin-6 levels in patients with reactive thrombocytosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22237

7 January 2021

Tumour necrosis factor-alpha, interleukin-1 beta and interleukin-6 in patients with renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22237

7 January 2021

Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22237

7 January 2021

Transplacental carcinogenesis by stilbestrol

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22237

7 January 2021

Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22237

7 January 2021

Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22237

7 January 2021

Platelets and cancer metastasis: a causal relationship?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22237

7 January 2021

Response of a human megakaryocytic cell line to thrombin: increase in intracellular free calcium and mitogen release

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22237

7 January 2021

Enhanced VEGF production and decreased immunogenicity induced by TGF-beta 1 promote liver metastasis of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22237

7 January 2021

Transforming growth factor beta1 (TGF-beta1) promotes endothelial cell survival during in vitro angiogenesis via an autocrine mechanism implicating TGF-alpha signaling

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22237

7 January 2021

Identifiers

DOI

10.1002/CNCR.22237

1 reference

15 August 2017

1 reference